Melatonin and regulation of the cardiovascular system;Melatonine et regulation du systeme cardiovasculaire

Therapie

Volumn 53, Issue 5, 1998, Pages 459-465

  Scalbert, E ^a   Guardiola Lemaitre B ^a   Delagrange, P ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Cardiovascular system; Circadian rhythms; Melatonin; Melatoninergic ligands; Suprachiasmatic nucleus

Indexed keywords

MELATONIN; MELATONIN RECEPTOR;

BRAIN CIRCULATION; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CONFERENCE PAPER; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RHYTHM; HUMAN; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; STROKE; SYMPATHETIC FUNCTION; VASOCONSTRICTION; VASODILATATION; ANIMAL; CIRCADIAN RHYTHM; CLINICAL TRIAL; DRUG EFFECT; HEMODYNAMICS; PHYSIOLOGY; RAT; REVIEW;

ANIMALS; CARDIOVASCULAR PHYSIOLOGY; CIRCADIAN RHYTHM; CLINICAL TRIALS; HEMODYNAMIC PROCESSES; HUMANS; MELATONIN; RATS;

EID: 0032150574     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (52)

1. Viswanathan M, Laitinen JT, Saavedra JM. Expression of melatonin receptors in arteries involved in thermoregulation. PNAS 1990; 87: 6200-6203.
2. Stankov B, Capsoni S, Lucini V et al. Autoradiographic localization of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus. Neuroscience 1992; 52: 459-468.
3. 1A melatonin receptors in human and rat cerebral and peripheral arteries: mRNA expression and functional pharmacology. Society for Neuroscience 1996; 22: 1400, abstract no. 551.19.
4. 1B melatonin receptor mRNA from rat superior cervical ganglia (SCG) and cerebral arteries. Society for Neuroscience 1997; 23: 1069, abstract no. 420.12.
5. Seltzer A, Viswanathan M, Saavedra JM. Melatonin-binding sites in brain and caudal arteries of the female rat during the estrous cycle and after estrogen administration. Endocrinology 1992; 130: 1896-1902.
6. Laitinen JT, Viswanathan M, Vakkuri O, Saavedra JM. Differential regulation of the rat melatonin receptors: selective age-associated decline and lack of melatonin-induced changes. Endocrinology 1992; 130: 2139-2144.
7. Viswanathan M, Laitinen JT, Saavedra JM. Differential expression of melatonin receptors in spontaneously hypertensive rats. Neuroendocrinology 1992; 56: 864-870.
8. 125I] iodomelatonin binding sites in the lung and heart: a link between the photoperiodic signal, melatonin and the cardiopulmonary system. Biol Signals 1993; 2: 228-236.
9. 3H] melatonin in human platelets. J Pineal Res 1992; 13: 60-65.
10. Evans BK, Mason R, Wilson VG. Evidence for direct vasoconstrictor activity of melatonin in 'pressurized' segments of isolated caudal artery from juvenile rats. Naunyn-Schmiedeberg's Arch Pharmacol 1992; 346: 362-365.
11. Ting KN, Dunn WR, Davies DJ et al. Studies on the vasoconstrictor action of melatonin and putative melatonin receptor ligands in the tail artery of juvenile Wistar rats. Br J Pharmacol 1997; 122: 1299-1306.
12. Krause DN, Barrios VE, Duckles SP. Melatonin receptors mediate potentiation of contractile responses to adrenergic nerve stimulation in rat caudal artery. Eur J Pharmacol 1995; 276: 207-213.
13. Geary GG, Krause DN, Duckles SP. Melatonin directly constricts rat cerebral arteries through modulation of potassium channels. Am J Physiol 1997; 273: H1530-H1536.
14. Viswanathan M, Scalbert E, Delagrange P et al. Melatonin receptors mediate contraction of the rat cerebral artery. Neuroreport 1997; 8: 3847-3849.
15. Weekley LB. Effects of melatonin on pulmonary and coronary vessels are exerted through perivascular nerves. Clin Autonomic Res 1993; 3: 45-47.
16. Satake N, Oe H, Sawada T, Shibata S. The mode of vasorelaxing action of melatonin in rabbit aorta. Gen Pharmac 1991; 22: 219-221.
17. Satake N, Oe H, Shibata S. Vasorelaxing action of melatonin in rat isolated aorta; possible endothelium dependent relaxation. Gen Pharmac 1991; 22: 1127-1133.
18. Monroe KK, Watts SW. The vascular reactivity of melatonin. Gen Pharmac 1998; 30: 31-35.
19. Duckles SP, Geary GG, Krause DN. Melatonin mediates vascular dilation via a distinct melatonin receptor subtype. Society for Neuroscience 1997; 23: 1517, abstract no. 595.12.
20. Capsoni S, Stankov BM, Fraschini F. Reduction of regional cerebral blood flow by melatonin in young rats. Neuroreport 1995; 6: 1346-1348.
21. Régrigny O, Delagrange P, Scalbert E et al. Melatonin improves cerebral circulation security margin in rats. Am J Physiol 1998, 275: H139-H144.
22. Fiorina P, Lattuada G, Ponari O et al. Impaired nocturnal melatonin excretion and changes of immunological status in ischaemic stroke patients. Lancet, 347: 692-693.
23. Chuang JI, Chen SS, Lin MT. Melatonin decreases brain serotonin release, arterial pressure and heart rate in rats. Pharmacology 1993; 47: 91-97.
24. Zanoboni A, Zanoboni-Muciaccia W. Experimental hypertension in pinealectomized rats. Life Sci 1967; 6: 2327-2331.
25. 2+]-dependent ATPase in cardiac sarcolemma. J Pineal Res 1993; 14: 178-183.
26. 3H-Nitrendipine binding in the heart. PSEBM 1994; 207: 34-37.
27. Viswanathan M, Hissa R, George JC. Suppression of sympathetic nervous system by short photoperiod and melatonin in the Syrian hamster. Life Sciences 1986; 38: 73-79.
28. Abete P, Bianco S, Calabrese C et al. Effects of melatonin in isolated rat papillary muscle. FEBS Lett 1997; 412: 79-85.
29. Reiter R, Tang L, Garcia JJ, Muñoz-Hoyos. Minireview: pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 1997; 60: 2255-2271.
30. Joyeux M, Godin-Ribuot D, Durand A et al. Melatonin and S 20098 protect against reperfusion arrhythmias in the isolated rat heart. Fundam Clin Pharmacol 1997; 11: 177.
31. Brugger P, Marktl W, Herold M. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 1995; 345: 1408.
32. Nagtegaal E, Smits M, Swart W et al. Melatonin secretion and coronary heart disease. Lancet 1995; 346: 1299.
33. 2 production by melatonin: evidence for a diurnal variation. J Clin Endocrinol Metab 1990; 70: 246-251.
34. Kornblihtt LI, Finocchiaro L, Molinas FC. Inhibitory effect of melatonin on platelet activation induced by collagen and arachidonic acid. J Pineal Res 1993; 14: 184-191.
35. 2 production by melatonin. Correlation with plasma melatonin levels. J Pineal Res 1991; 11: 135-139.
36. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79: 733-743.
37. Krantz DS, Kop WJ, Gabbay FH et al. Circadian variation of ambulatory myocardial ischemia. Triggering by daily activities and evidence for an endogenous circadian component. Circulation 1996; 93: 1364-1371.
38. Janssen BJA, Tyssen CM, Duindam H, Rietveld WJ. Suprachiasmatic lesions eliminate 24-h blood pressure variability in rats. Physiology and Behavior 1994; 55: 307-311.
39. Witte K, Schnecko A, Buijs RM et al. Effects of SCN lesions on circadian blood pressure rhythm in normotensive and transgenic hypertensive rats. Chronobiol Int 1998; 15: 135-145.
40. Witte K, Lemmer B. Free-running rhythms in blood pressure and heart rate in normotensive and transgenic hypertensive rats. Chronobiol Int 1995; 12: 237-247.
41. Lemmer B, Mattes A, Böhm M, Ganten D. Circadian blood pressure variation in transgenic hypertensive rats. Hypertension 1993; 22: 97-101.
42. Sundberg S, Kohvakka A, Gordin A. Rapid reversal of circadian blood pressure rhythm in shift workers. J Hypertension 1988; 6: 393-396.
43. Sternberg H, Rosenthal T, Shamiss A, Green M. Altered circadian rhythm of blood pressure in shift workers. J Human Hypertension 1995; 9: 349-353.
44. Kawachi I, Colditz GA, Stampfer MJ et al. Prospective study of shift work and risk of coronary heart disease in women. Circulation 1995; 92: 3178-3182.
45. Yamamoto Y, Akiguchi I, Oiwa K et al. Diminished nocturnal blood pressure decline and lesion site in cerebrovascular disease. Stroke 1995; 26: 829-833.
46. Kario K, Matsuo T, Kobayashi H et al. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Adranced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27: 130-135.
47. Okatani Y, Watanabe K, Wakatsuki A et al. Melatonin inhibits vasospastic action of hydrogen peroxide in human umbilical artery. J Pineal Res 1997; 22: 163-168.
48. Mahle CD, Goggins GD, Agarwal P et al. Melatonin modulates vascular smooth muscle tone. J Biol Rhythms 1997; 12: 690-696.
49. Cagnacci A, Arangino S, Angiolucci M et al. Potentially beneficial cardiovascular effects of melatonin administration in women. J Pineal Res 1997; 22: 16-19.
50. Octavio JA, Jakubowicz S, Pérez-Gonzalez JF. Melatonin and nocturnal cardiovascular parameters in young healthy people. Chronobiol Int 1997; 14: 127, abstract no. 252.
51. Lusardi P, Fogari R. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24 hour ABPM study. J Hypertens 1997; 15: S 35, abstract no. P1.90.
52. Malik FS, Mehra MR, Ali A et al. Nocturnal melatonin release impairment and clinical effects of exogenous melatonin in chronic heart failure. J Am Coll Cardiol 1997; 29: 370A, abstract no. 783.3.